Completed OBSERVATIONAL NCT04660396

Monitoring Outpatient Blood VolumE in Heart Failure (MOVE-HF)

Sponsor: Daxor Corporation

Interventions BVA-100

Updated 6 times since 2021 Last updated: Sep 28, 2023 Started: Sep 16, 2021 Primary completion: Jul 15, 2022 Completion: Jul 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Heart Failure, this trial is completed. The trial is conducted by Daxor Corporation and has accumulated 6 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Oct 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
May 2022 — Oct 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2021 — May 2022 [monthly]

Not Yet Recruiting

▶ Show 1 earlier version

Jan 2021 — May 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daxor Corporation
Geisinger Clinic

Data source: Daxor Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Danville, United States